Immunotherapy Plus Chemoradiation Improves NSCLC Outcomes - AJMC.com Managed Markets Network

New real-world evidence on non–small cell lung cancer (NSCLC) aligns with the results of a 2017 clinical trial.

New data from more than 20,000 patients with stage III lung cancer suggest that immunotherapy after chemotherapy and radiation can improve outcomes. This studys findings confirmed the results of the … [+3797 chars]

full article...